Prospective study of infective endocarditis among injection drug users.

The changing face of infective endocarditis. Heart (2005) 3.15

Injection drug use and right sided endocarditis. Heart (2003) 1.49

The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (2005) 1.32

Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis (2006) 1.11

Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis (2012) 1.09

Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis. BMC Infect Dis (2008) 1.00

PCR-electrospray ionization mass spectrometry for direct detection of pathogens and antimicrobial resistance from heart valves in patients with infective endocarditis. J Clin Microbiol (2013) 1.00

Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia. Int J Microbiol (2010) 0.91

Management of HIV infection in patients with substance use problems. Curr Infect Dis Rep (2008) 0.90

Infective Endocarditis in Intravenous Drug Abusers. Curr Infect Dis Rep (2003) 0.89

Tricuspid Endocarditis and Septic Pulmonary Embolism in an Intravenous Drug User with advanced HIV Infection. Oman Med J (2011) 0.87

The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. J Acquir Immune Defic Syndr (2010) 0.84

Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial. J Subst Abuse Treat (2012) 0.81

Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction (2012) 0.77

Cotton Fever: Does the Patient Know Best? J Gen Intern Med (2016) 0.75

Infective endocarditis involving an apparently structurally normal valve: new epidemiological trend? Korean J Intern Med (2015) 0.75

A Complicated Case of Triple Valve Infective Endocarditis in an IV Drug User with a Bicuspid Aortic Valve Requiring Three Separate Salvage Operations: A Case Report and Literature Review. Case Rep Cardiol (2015) 0.75

Endocarditis caused by unusual Streptococcus species (Streptococcus pluranimalium). Hippokratia (2016) 0.75

Embolization of a huge tricuspid valve vegetation in a patient with intravenous drug abuse and HIV infection with an remarkable recovery. Neth Heart J (2006) 0.75

Cardiac surgery for infective endocarditis in patients with intravenous drug use. Interact Cardiovasc Thorac Surg (2016) 0.75

Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital. Medicine (Baltimore) (2016) 0.75

Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs. J Addict Med (2017) 0.75

Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (2009) 22.53

Diagnosis, management, and treatment of hepatitis C. Hepatology (2004) 11.62

A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (2006) 10.18

Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med (2002) 10.07

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 8.95

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

Protection against persistence of hepatitis C. Lancet (2002) 5.94

Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse (2002) 5.65

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60

The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health (2004) 5.21

Exceeding the limits of liver histology markers. J Hepatol (2008) 5.06

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A (2006) 4.54

Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction (2003) 4.25

The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev (2005) 4.09

Television images and psychological symptoms after the September 11 terrorist attacks. Psychiatry (2002) 4.07

Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. Am J Epidemiol (2003) 3.93

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78

HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56

Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev (2002) 3.45

The social epidemiology of substance use. Epidemiol Rev (2004) 3.41

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41

Challenges and facilitating factors in sustaining community-based participatory research partnerships: lessons learned from the Detroit, New York City and Seattle Urban Research Centers. J Urban Health (2006) 3.36

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health (2004) 3.32

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29

Hepatitis C and progression of HIV disease. JAMA (2002) 3.15

Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep (2002) 3.14

Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health (2006) 3.10

Occult hepatitis B. Lancet Infect Dis (2002) 3.09

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis (2005) 3.06

IL28B and the control of hepatitis C virus infection. Gastroenterology (2010) 3.02

Urban health: evidence, challenges, and directions. Annu Rev Public Health (2005) 3.02

In vivo imaging of glucose uptake and metabolism in tumors. Nat Med (2013) 3.01

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology (2008) 3.00

Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology (2011) 2.99

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97

Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med (2005) 2.75

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology (2002) 2.71

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis (2004) 2.71

Hepatitis C in the HIV-Infected Person. Ann Intern Med (2003) 2.67

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol (2005) 2.64

Limited uptake of hepatitis C treatment among injection drug users. J Community Health (2008) 2.61

Mental health service and medication use in New York City after the September 11, 2001, terrorist attack. Psychiatr Serv (2004) 2.58

Needlestick transmission of hepatitis C. JAMA (2002) 2.55

Cities and population health. Soc Sci Med (2005) 2.53

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology (2005) 2.52

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (2009) 2.45

What predicts psychological resilience after disaster? The role of demographics, resources, and life stress. J Consult Clin Psychol (2007) 2.39

Urban built environment and depression: a multilevel analysis. J Epidemiol Community Health (2005) 2.34

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS (2005) 2.34

Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol (2007) 2.33

Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol (2002) 2.29

Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology (2009) 2.24

High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther (2011) 2.20

Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health (2006) 2.20

Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol (2004) 2.19

Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med (2005) 2.16

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology (2012) 2.14

Psychological resilience after disaster: New York City in the aftermath of the September 11th terrorist attack. Psychol Sci (2006) 2.08

Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol (2010) 2.07

Primary care and health insurance among women released from New York City jails. J Health Care Poor Underserved (2006) 2.04

High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend (2002) 2.04

Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis (2005) 2.02

Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend (2003) 2.01

APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend (2005) 1.94

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS (2007) 1.92

Cross-genotype immunity to hepatitis C virus. J Virol (2004) 1.92

Hispanic ethnicity and post-traumatic stress disorder after a disaster: evidence from a general population survey after September 11, 2001. Ann Epidemiol (2004) 1.91

Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr (2003) 1.89

Hepatitis C virus infection and incident type 2 diabetes. Hepatology (2003) 1.89

Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis (2004) 1.89

Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis (2005) 1.89

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA (2012) 1.88

Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86

Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS (2003) 1.86

Probable cigarette dependence, PTSD, and depression after an urban disaster: results from a population survey of New York City residents 4 months after September 11, 2001. Psychiatry (2005) 1.84

Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83

HLA-Cw*04 and hepatitis C virus persistence. J Virol (2002) 1.83

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS (2006) 1.82

Utilization of mental health services following the September 11th terrorist attacks in Manhattan, New York City. Int J Emerg Ment Health (2002) 1.82

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS (2003) 1.81

Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis (2009) 1.80

Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79

Changes in blood-borne infection risk among injection drug users. J Infect Dis (2011) 1.74